ClinicalTrialsFinder

Major Depressive Disorder With Anxious Distress Clinical Trials in Bialystok

1 recruitingBialystok, Poland

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

Major Depressive Disorder (MDD)Major Depressive Disorder With Anxious Distress
Seaport Therapeutics360 enrolled45 locationsNCT07065240